MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?

MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?
复制标题

DOI:
10.1186/1471-2369-11-8
复制
发表时间:
2010-06-01
期刊:
影响因子:
2.3
通讯作者:
Krzesinski JM
Krzesinski JM
中科院分区:
医学4区
文献类型:
--
作者:
Delanaye P;Cavalier E;Mariat C;Maillard N;Krzesinski JM

文献摘要

参考文献

被引文献

相似文献

根据NHANES研究,3期慢性肾脏病(CKD)的患病率正在增加。使用MDRD研究公式估算肾小球滤过率(GFR)计算患病率。最近,一个新的估计肌酐的基础上,CKD-EPI方程,已被提出,这是假定更好地执行在正常的GFR范围。本研究的目的是使用MDRD或CKD-EPI研究方程测量人群中3期CKD患病率的差异。CKD筛查在比利时列日省组织。在自愿的基础上,45至75岁的人被邀请接受检查。通过MDRD研究方程和“新”CKD-EPI方程估计GFR。接受筛查的人口为1992人(男性占47%)。平均血清肌酐为0.86 ± 0.20 mg/dL。使用MDRD或CKD-EPI方程,该人群中3期CKD的患病率分别为11.04%和7.98%。MDRD研究方程中3期CKD的患病率显著较高(p <0.0012)。根据用于估计GFR、MDRD或CKD-EPI研究方程的方法,3期CKD的患病率变化很大。这种差异是重要的,必须通过使用参考方法测量的GFR的额外研究来证实和解释。
Prevalence of stage 3 chronic kidney disease (CKD) is increasing according to the NHANES study. Prevalence has been calculated using the MDRD study equation for estimating glomerular filtration rate (GFR). Recently, a new estimator based on creatinine, the CKD-EPI equation, has been proposed which is presumed to better perform in normal GFR ranges. The aim of the study was to measure the difference in prevalence of stage 3 CKD in a population using either the MDRD or the CKD-EPI study equations. CKD screening is organized in the Province of Liège, Belgium. On a voluntary basis, people aged between 45 and 75 years are invited to be screened. GFR is estimated by the MDRD study equation and by the "new" CKD-EPI equations. The population screened consisted in 1992 people (47% of men). Mean serum creatinine was 0.86 ± 0.20 mg/dL. The prevalence of stage 3 CKD in this population using the MDRD or the CKD-EPI equations was 11.04 and 7.98%, respectively. The prevalence of stage 3 CKD is significantly higher with the MDRD study equation (p < 0,0012). Prevalence of stage 3 CKD varies strongly following the method used for estimating GFR, MDRD or CKD-EPI study equations. Such discrepancies are of importance and must be confirmed and explained by additional studies using GFR measured with a reference method.
DOI: 10.1093/ndt/gfn473
发表时间: 2009-01-01
影响因子: 6.1
作者:
Douville, Pierre;Martel, Ariane R.;Agharazii, Mohsen
通讯作者: Agharazii, Mohsen
DOI: 10.1681/asn.2005121273
发表时间: 2006-08-01
影响因子: 13.6
作者:
Hallan, Stein I.;Coresh, Josef;Holmen, Jostein
通讯作者: Holmen, Jostein
DOI: 10.7326/0003-4819-145-4-200608150-00004
发表时间: 2006-08-15
影响因子: 39.2
作者:
Levey, Andrew S.;Coresh, Josef;Van Lente, Frederick
通讯作者: Van Lente, Frederick
DOI: 10.1001/jama.298.17.2038
发表时间: 2007-11-07
影响因子: 120.7
作者:
Coresh, Josef;Selvin, Elizabeth;Levey, Andrew S.
通讯作者: Levey, Andrew S.
DOI: 10.7326/0003-4819-150-9-200905050-00006
发表时间: 2009-05-05
影响因子: 39.2
作者:
Levey AS;Stevens LA;Schmid CH;Zhang YL;Castro AF 3rd;Feldman HI;Kusek JW;Eggers P;Van Lente F;Greene T;Coresh J;CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
通讯作者: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)